CONVERSANO, ESTER
CONVERSANO, ESTER
DIPARTIMENTO DI MEDICINA MOLECOLARE
A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance
2024 Conversano, E; Debiec, H; Colucci, M; Emma, F; Ronco, P; Vivarelli, M
A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood
2024 Riganati, M; Zotta, F; Candino, A; Conversano, E; Gargiulo, A; Scarsella, M; Lo Russo, A; Bettini, C; Emma, F; Vivarelli, M; Colucci, M
Advances in Complement Inhibitory Strategies for the Treatment of Glomerular Disease: A Rapidly Evolving Field
2025 Conversano, Ester; Vivarelli, Marina
Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patients
2025 Riganati, Martina; Conversano, Ester; Zotta, Federica; Gargiulo, Antonio; Antonucci, Luca; Giannini, Carolina; Ricci, Giulia; Diomedi-Camassei, Francesca; Debiec, Hanna; Ronco, Pierre; Emma, Francesco; Vivarelli, Marina; Colucci, Manuela
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
2024 Balestra, E; Barbi, E; Ceconi, V; Di Maso, V; Conversano, E; Pennesi, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance | 2024 | Conversano, E; Debiec, H; Colucci, M; Emma, F; Ronco, P; Vivarelli, M | |
| A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood | 2024 | Riganati, M; Zotta, F; Candino, A; Conversano, E; Gargiulo, A; Scarsella, M; Lo Russo, A; Bettini, C; Emma, F; Vivarelli, M; Colucci, M | |
| Advances in Complement Inhibitory Strategies for the Treatment of Glomerular Disease: A Rapidly Evolving Field | 2025 | Conversano, Ester; Vivarelli, Marina | |
| Comparison of B lymphocyte profile between membranous nephropathy and idiopathic nephrotic syndrome pediatric patients | 2025 | Riganati, Martina; Conversano, Ester; Zotta, Federica; Gargiulo, Antonio; Antonucci, Luca; Giannini, Carolina; Ricci, Giulia; Diomedi-Camassei, Francesca; Debiec, Hanna; Ronco, Pierre; Emma, Francesco; Vivarelli, Marina; Colucci, Manuela | |
| Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy | 2024 | Balestra, E; Barbi, E; Ceconi, V; Di Maso, V; Conversano, E; Pennesi, M |